Normal lung function requires the presence of adequate amounts of functional alveolar surfactant. When the lung is in a steady-state the rates of release and removal of surfactant must be equal. Several studies suggest that one pathway for the clearance may be recycling of surfactant from the alveoli back into the type II cell. The overall goal of this project is to study some of the factors involved in recycling. Recent studies in our laboratory suggest that alveolar surfactant obtained by lung lavage can be divided by differential centrifugation into subfractions which appear to be in a metabolic sequence. The heavier, more dense material appears to be a precursor to the lighter, less dense material. The heavier (""""""""new"""""""") material contains some tubular myelin and vesicles and is surface active. The lighter, less sedimentable (""""""""old') material contains vesicular structures and is relatively inactive. A model consistent with these findings is that tubular myelin, formed from newly released lamellar body material, generates a surface film which is eventually reduced to vesicular structures small enough to be endocytosed back into type II cells. This endocytosed material is recylced. I am proposing that the lighter, less dense material is the subfraction of surfactant which is preferentially recycled back intotype II cells. I am also proposing that surfactant apoproteins serve as ligands which can mediate the endocytosis. I propose to test this hypothesis with three specific aims. 1) To determine if an old subfraction of surfactant is taken up into the lung faster than newly released material. These experiments will be done by measuring the rates of uptake of radioactively labeled new and old surfactant given to intact animals and isolated type II cells. 2) To determine what proteins are present in the subfractions of new and old surfactant. Electrophoresis and antibodies will be used to identify the proteins of the subfractions. 3) To determine whether the proteins of the old or new material relate to the uptake of phospholipids. Proteins of the subfractions will be labeled with radioactive amino acids and the rates of uptake of the proteins will be compared.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Unknown (R23)
Project #
5R23HL030923-03
Application #
3448540
Study Section
Respiratory and Applied Physiology Study Section (RAP)
Project Start
1983-07-01
Project End
1986-06-30
Budget Start
1985-07-01
Budget End
1986-06-30
Support Year
3
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Perfect, John R (2014) Cryptococcosis: a model for the understanding of infectious diseases. J Clin Invest 124:1893-5
Geunes-Boyer, Scarlett; Beers, Michael F; Perfect, John R et al. (2012) Surfactant protein D facilitates Cryptococcus neoformans infection. Infect Immun 80:2444-53
Geunes-Boyer, Scarlett; Heitman, Joseph; Wright, Jo Rae et al. (2010) Surfactant protein D binding to Aspergillus fumigatus hyphae is calcineurin-sensitive. Med Mycol 48:580-8
Geunes-Boyer, Scarlett; Oliver, Timothy N; Janbon, Guilhem et al. (2009) Surfactant protein D increases phagocytosis of hypocapsular Cryptococcus neoformans by murine macrophages and enhances fungal survival. Infect Immun 77:2783-94
Lord, Christopher A; Savitsky, David; Sitcheran, Raquel et al. (2009) Blimp-1/PRDM1 mediates transcriptional suppression of the NLR gene NLRP12/Monarch-1. J Immunol 182:2948-58
Zaas, David W; Swan, Zachary D; Brown, Bethany J et al. (2009) Counteracting signaling activities in lipid rafts associated with the invasion of lung epithelial cells by Pseudomonas aeruginosa. J Biol Chem 284:9955-64